See more : Altitude Acquisition Corp. (ALTU) Income Statement Analysis – Financial Results
Complete financial analysis of CFN Enterprises Inc. (CNFN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CFN Enterprises Inc., a leading company in the Advertising Agencies industry within the Communication Services sector.
- Baidu, Inc. (9888.HK) Income Statement Analysis – Financial Results
- Medaro Mining Corp. (MEDA.CN) Income Statement Analysis – Financial Results
- China Ecotek Corporation (1535.TW) Income Statement Analysis – Financial Results
- San Miguel Corporation (SMGBF) Income Statement Analysis – Financial Results
- Alviva Holdings Limited (AVV.JO) Income Statement Analysis – Financial Results
CFN Enterprises Inc. (CNFN)
Industry: Advertising Agencies
Sector: Communication Services
Website: https://www.cfnenterprisesinc.com
About CFN Enterprises Inc.
CFN Enterprises Inc. engages in the sponsored content and marketing activities for legal CBD, cannabis, and psychedelics industries in the United States. The company also manufactures CBD products for growers, pharmaceutical, wellness providers, and retailers' needs. It provides sponsored content, including articles, press releases, videos, podcasts, advertisements and other media, email advertisements, and other marketing campaigns. The company also operates various media platforms, such as CannabisFN.com, the CannabisFN iOS app, the CFN Media YouTube channel, the CFN Media podcast, and other venues to educate and inform investors interested in the cannabis industry. It distributes its content to various online platforms, which include CannabisFN.com website, press releases, financial news syndicates, search engines, YouTube, iTunes, Twitter, Instagram, Facebook, LinkedIn, and others. The company was formerly known as Accelerize Inc. and changed its name to CFN Enterprises Inc. in October 2019. CFN Enterprises Inc. was founded in 2001 and is based in Whitefish, Montana.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.54M | 4.32M | 3.16M | 506.49K | 864.92K | 21.73M | 24.10M | 23.75M | 21.40M | 16.46M | 9.65M | 5.80M | 3.46M | 3.70M | 3.87M | 3.80M | 1.03M | 199.21K | 9.53K |
Cost of Revenue | 3.02M | 6.51M | 3.54M | 536.74K | 864.83K | 9.08M | 9.07M | 8.23M | 6.49M | 4.14M | 2.06M | 902.78K | 512.63K | 1.45M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 514.69K | -2.19M | -381.85K | -30.25K | 84.00 | 12.65M | 15.04M | 15.52M | 14.90M | 12.32M | 7.59M | 4.90M | 2.95M | 2.25M | 3.87M | 3.80M | 1.03M | 199.21K | 9.53K |
Gross Profit Ratio | 14.55% | -50.83% | -12.09% | -5.97% | 0.01% | 58.23% | 62.39% | 65.35% | 69.65% | 74.82% | 78.63% | 84.44% | 85.20% | 60.79% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.17M | 4.41M | 4.02M | 4.63M | 3.14M | 1.43M | 933.03K | 517.67K | 418.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.30M | 7.35M | 8.34M | 9.00M | 6.22M | 2.52M | 1.31M | 2.22M | 1.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.30M | 4.38M | 3.61M | 7.36M | 6.17M | 3.83M | 2.11M | 1.09M | 973.57K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.63M | 2.64M | 2.69M | 1.20M | 2.24M | 12.60M | 11.73M | 11.95M | 16.36M | 12.39M | 6.35M | 3.58M | 3.31M | 2.46M | 5.77M | 8.75M | 4.05M | 2.56M | 0.00 |
Other Expenses | 8.68M | 34.21K | 5.82M | 10.00K | 2.90M | 621.00 | 748.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 14.31M | 2.64M | 2.69M | 1.20M | 2.24M | 16.77M | 16.14M | 15.97M | 20.99M | 15.54M | 7.78M | 4.52M | 3.83M | 2.88M | 5.77M | 8.75M | 4.05M | 2.56M | 0.00 |
Cost & Expenses | 17.33M | 9.15M | 6.23M | 1.74M | 3.11M | 25.84M | 25.21M | 24.21M | 27.48M | 19.68M | 9.84M | 5.42M | 4.34M | 4.33M | 5.77M | 8.75M | 4.05M | 2.56M | 0.00 |
Interest Income | 321.00 | 113.00 | 10.01K | 19.00 | 131.00 | 0.00 | 748.00 | 20.83K | 88.56K | 18.19K | 14.75K | 1.73K | 0.00 | 0.00 | 0.00 | 0.00 | 18.25K | 0.00 | 0.00 |
Interest Expense | 1.63M | 694.38K | 93.17K | 51.62K | 13.99K | 2.58M | 1.21M | 1.22M | 266.88K | 49.91K | 39.87K | 167.55K | 316.94K | 129.39K | 119.69K | 32.30K | 18.25K | 521.00 | 0.00 |
Depreciation & Amortization | 470.63K | 2.17M | 551.38K | 1.81K | 38.19K | 604.26K | 702.28K | 761.28K | 1.34M | 1.32M | 113.59K | 35.80K | 20.34K | 202.58K | 313.53K | 412.62K | 199.40K | 58.64K | 0.00 |
EBITDA | -13.08M | -7.06M | -11.56M | -1.29M | -5.97M | -687.50K | -502.93K | -1.87M | -4.66M | -1.88M | -56.30K | 418.47K | -881.34K | -424.92K | -1.58M | -4.62M | -2.80M | -2.31M | 9.53K |
EBITDA Ratio | -369.87% | -61.07% | -82.74% | -240.45% | -255.04% | -16.14% | -4.58% | 1.39% | -21.77% | -11.43% | -0.58% | 7.21% | -24.77% | -11.47% | -40.80% | -119.80% | -273.42% | -1,157.30% | 100.00% |
Operating Income | -13.79M | -8.45M | -12.43M | -1.23M | -2.24M | -8.84M | -1.10M | -2.65M | -6.09M | -3.22M | -184.64K | 380.94K | -878.12K | -627.50K | -1.89M | -4.96M | -3.02M | -2.36M | 9.53K |
Operating Income Ratio | -389.88% | -195.77% | -393.59% | -242.78% | -259.47% | -40.67% | -4.58% | -11.16% | -28.44% | -19.57% | -1.91% | 6.57% | -25.36% | -16.94% | -48.89% | -130.67% | -292.77% | -1,186.73% | 100.00% |
Total Other Income/Expenses | -1.39M | -1.47M | 224.68K | -112.97K | -13.86K | -7.31M | -1.32M | -1.20M | -178.32K | -31.72K | -25.12K | -165.82K | -340.82K | -536.57K | -119.69K | -32.30K | -278.72K | -521.00 | 0.00 |
Income Before Tax | -15.19M | -9.92M | -12.20M | -1.34M | -6.03M | -11.42M | -2.42M | -3.85M | -6.26M | -3.25M | -209.76K | 215.12K | -1.22M | -756.89K | -2.01M | -4.99M | -3.30M | 0.00 | 0.00 |
Income Before Tax Ratio | -429.29% | -229.81% | -386.48% | -265.09% | -696.67% | -52.54% | -10.06% | -16.21% | -29.28% | -19.76% | -2.17% | 3.71% | -35.20% | -20.44% | -51.98% | -131.52% | -319.82% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 4.41M | 98.76K | 142.04K | -14.38M | 621.00 | 507.40K | 1.22M | 88.56K | 18.19K | -288.79K | -276.10K | 275.10K | 0.00 | 0.00 | 0.00 | -296.98K | 521.00 | -2.56K |
Net Income | -15.19M | -14.33M | -12.30M | -1.48M | 8.37M | -11.42M | -2.42M | -3.85M | -6.26M | -3.25M | 93.78K | 492.95K | -1.18M | -756.89K | -2.01M | -4.99M | -3.00M | -2.36M | 2.56K |
Net Income Ratio | -429.29% | -331.86% | -389.60% | -293.13% | 967.21% | -52.54% | -10.06% | -16.21% | -29.28% | -19.76% | 0.97% | 8.50% | -33.99% | -20.44% | -51.98% | -131.52% | -291.00% | -1,186.99% | 26.82% |
EPS | -0.25 | -0.42 | -0.76 | -0.22 | -2.01 | -2.59 | -0.60 | -0.90 | -1.50 | -0.80 | -0.06 | 0.04 | -0.47 | -0.36 | -1.09 | -2.97 | -2.13 | -1.89 | 0.00 |
EPS Diluted | -0.25 | -0.42 | -0.76 | -0.22 | -2.01 | -2.59 | -0.56 | -0.89 | -1.48 | -0.80 | -0.06 | 0.04 | -0.47 | -0.36 | -1.09 | -2.97 | -2.13 | -1.89 | 0.00 |
Weighted Avg Shares Out | 61.23M | 34.26M | 16.23M | 6.78M | 5.60M | 4.40M | 4.04M | 4.28M | 4.18M | 4.06M | 3.80M | 3.50M | 2.49M | 2.10M | 1.85M | 1.68M | 1.41M | 1.25M | 1.25M |
Weighted Avg Shares Out (Dil) | 61.23M | 34.26M | 16.23M | 6.78M | 5.60M | 4.40M | 4.36M | 4.34M | 4.24M | 4.06M | 4.90M | 3.96M | 2.49M | 2.10M | 1.85M | 1.68M | 1.41M | 1.25M | 1.25M |
Update: CFN Media & Intro-act Collaborate to Launch Unified Digital Outreach Program for the Cannabis Industry
CFN Enterprises Inc. Becomes a NEO Exchange Trusted Service Provider Celebrated with Market Open
CFN Enterprises Inc. Launches Cannabis News Series to Broadcast on Bloomberg, Newsmax & Fox Business
How California Is Dominating the Cannabis Brand Landscape
Silo Pharma Inc. Engages CFN Enterprises Inc. to Reach Psychedelics Investor Audience
Royalty Streaming: A Different Way to Get Exposure to the Cannabis Market
FinCanna Capital Engages CFN Enterprises Inc. to Reach New Cannabis Investors
CFN Enterprises Inc. Adds Leading Psychedelic Wellness Brand to Client Roster
The Canadian Securities Exchange (The CSE), CFN Media and Zuber Lawler Announce Their Latest "Investing in Psychedelics" Virtual Conference Series
'Psychedelics Market Update' by PsyIndex.com
Source: https://incomestatements.info
Category: Stock Reports